Evidence map›Paper›PMID 40715438›Full record

ArticleNPJ precision oncology2025

Cell graph analysis in hepatocellular carcinoma: predicting local recurrence and identifying spatial relationship biomarkers.

Yizhe Yuan, Ziyin Zhao, Xin Fang, Qing Zhang, Wenqing Zhong, Midie Xu, Gongqi Li, Rushi Jiao, Heng Yu, Ruoxi Wang and 9 more

Abstract read
In one paragraph

Article in NPJ precision oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Yizhe Yuan *Institute of Medical Robotics, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.
Ziyin Zhao *Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, China.
Xin FangInstitute of Medical Robotics, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.
Qing ZhangSchool of Medical Technology, Qiqihar Medical University, Heilongjiang, China.
Wenqing ZhongDepartment of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, China.
Midie XuDepartment of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Gongqi LiSchool of Pathology, Qiqihar Medical University, Heilongjiang Province, China.
Rushi JiaoInstitute of Medical Robotics, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.
Heng YuDepartment of Computer Science, Stanford University, Stanford, USA.
Ruoxi WangInstitute of Medical Robotics, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.
Shuyu LiuInstitute of Medical Robotics, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.
Weitao ZuInstitute of Medical Robotics, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.
Bingsen XueInstitute of Medical Robotics, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.
Yuze ChenInstitute of Medical Robotics, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.
Chengxiang WangInstitute of Medical Robotics, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.
Ya ZhangShanghai Artificial Intelligence Laboratory, Shanghai, China.
Minghui LiangSchool of Medical Technology, Qiqihar Medical University, Heilongjiang, China. lmh5612@126.com.
Bing HanDepartment of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, China. hanbing@qduhospital.cn.
Cheng JinInstitute of Medical Robotics, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China. chengjin520@sjtu.edu.cn.

Funding

Joint Guidance Project of the Qiqihar City Science and Technology Program LHYD-202016National Key R&D Program of China 2022YFB4702702Science and Technology Program of Shinan District of Qingdao City 2022-4-006-YY
6 · The paper itself

Abstract

A whole pathology section contains approximately 1,000,000 cells of various types, this large-scale heterogeneity of cells and non-cellular constituents constructs a mutually competitive community. Conventional pixel-based visual processing techniques are insufficient to accurately capture the complexities inherent with cell-entity deployment and formation strategy. Here, we conquered segmentation and classification of all cells on the whole pathology sections from 387 hepatocellular carcinoma (HCC) patients across six cohorts with 57 pathologists assisted. Further, an AI system called Hybrid Graph Neural Network-Transformer system (HGTs) was proposed. It precisely predicted local recurrence of postoperative HCC by analyzing cell interactions across multiple scales, from cell-to-cell, cell-community, to tissue-level interactions. The proposed HGTs outperformed existing SOTA methods, with the C-index improving by 23.1% to reach 0.823, by further integrating multimodal data, including clinical information and immunohistochemical markers. A set of spatial relational biomarkers influencing tumor prognosis was discovered and quantitatively validated. They include the frequency of tumor-lymphocyte and tumor-tumor interactions, the distribution and sparsity of key cellular communities, and the degree of fibrosis in adjacent peritumoral tissues. Utilizing the anti-tumor potential of this marker set, we're developing therapies to enhance the immune system's fight against cancer. All cell semantic segmentation datasets and code are publicly available: https://github.com/Yuan1z0825/HGTs .

Identifiers

PMID40715438
PMCPMC12297246

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.